Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
20.28
-0.37 (-1.79%)
At close: Dec 5, 2025, 4:00 PM EST
20.17
-0.11 (-0.57%)
After-hours: Dec 5, 2025, 5:23 PM EST
Dyne Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 64.46 | 62.48 | 31.4 | 28.2 | 28.72 | 13.45 | |
| Research & Development | 384.71 | 281.41 | 210.76 | 142.76 | 121.31 | 45.2 | |
| Operating Expenses | 449.16 | 343.89 | 242.16 | 170.96 | 150.03 | 58.65 | |
| Operating Income | -449.16 | -343.89 | -242.16 | -170.96 | -150.03 | -58.65 | |
| Interest Expense | -3 | - | - | - | - | -0.4 | |
| Interest & Investment Income | 29.79 | 26.92 | 7.64 | 2.92 | 0.74 | 0.06 | |
| Currency Exchange Gain (Loss) | -1.46 | -0.49 | -1.39 | -0.02 | - | - | |
| Other Non Operating Income (Expenses) | - | - | - | - | - | -0.45 | |
| EBT Excluding Unusual Items | -423.82 | -317.45 | -235.91 | -168.07 | -149.28 | -59.44 | |
| Gain (Loss) on Sale of Investments | 0.02 | 0.04 | -0.02 | -0.03 | -0.01 | - | |
| Pretax Income | -423.8 | -317.42 | -235.94 | -168.1 | -149.29 | -59.44 | |
| Net Income | -423.8 | -317.42 | -235.94 | -168.1 | -149.29 | -59.44 | |
| Net Income to Common | -423.8 | -317.42 | -235.94 | -168.1 | -149.29 | -59.44 | |
| Shares Outstanding (Basic) | 117 | 94 | 60 | 52 | 51 | 14 | |
| Shares Outstanding (Diluted) | 117 | 94 | 60 | 52 | 51 | 14 | |
| Shares Change (YoY) | 39.30% | 57.74% | 14.83% | 2.13% | 253.54% | 489.30% | |
| EPS (Basic) | -3.62 | -3.37 | -3.95 | -3.23 | -2.93 | -4.13 | |
| EPS (Diluted) | -3.62 | -3.37 | -3.95 | -3.23 | -2.93 | -4.13 | |
| Free Cash Flow | -397.01 | -294.75 | -188.89 | -156.71 | -123.18 | -47.67 | |
| Free Cash Flow Per Share | -3.39 | -3.13 | -3.17 | -3.02 | -2.42 | -3.31 | |
| EBITDA | -447.19 | -342.21 | -240.49 | -169.28 | -148.94 | -57.95 | |
| D&A For EBITDA | 1.98 | 1.67 | 1.67 | 1.68 | 1.09 | 0.7 | |
| EBIT | -449.16 | -343.89 | -242.16 | -170.96 | -150.03 | -58.65 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.